Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


Human Genetic Testing Center Receives International Quality Accreditation in Germany
IntegraGen Awarded ISO 17025 Accreditation for Its Molecular Diagnostics Center in Bonn


Paris, France, and Bonn, Germany, 14 September 2006 … IntegraGen, the personalized healthcare company focused on the development and commercialization of genetic tests for complex diseases, announced today that its German Competence Centre based in Bonn has received accreditation under ISO Standard 17025 for performing human genetic analyses. The Center has established a leading position with regards to genetic testing for diabetes and offers a comprehensive panel of genetic tests, together with counseling.

Jorg Leenings, Head of Sales and Marketing, said “Our laboratory is headed by scientists that have been amongst the very first to introduce diagnostic sequencing into human genetics. This experience allows us to implement genetic analysis in the fastest and most cost-effective way. The ISO accreditation is an endorsement of the very highest standards in good laboratory practice that we have established”.

Germany currently has some of the highest levels of diabetes in the world, having 6.3 million people affected by it according to the International Diabetes Federation. Genes for most of the monogenic hereditary forms of the disease have been identified and IntegraGen offers tests for these including: MODY (Maturity Onset Diabetes of the Young); Mitochondrial Diabetes; Neonatal Diabetes: and Congenital hyperinsulinism. Accurate identification of the mutation causing the diabetes has considerable advantages for the patient and helps direct the correct drug treatment or intervention. IntegraGen is also developing a number of additional tests for other genes that are linked to the development of diabetes.

“The ability to screen for genetic predisposition to complex diseases is becoming increasingly important in healthcare. By identifying genes which may lead to future illness, more effective personalised prevention programs and treatments are possible. Early and accurate genetic diagnosis of chronic conditions such as diabetes is therefore extremely important and, combined with genetic counselling services we can also make sure patients are fully informed about their conditions” said Dr Jan Mous, President and CEO of IntegraGen.

ISO 17025 is an international standard that assesses the technical competency of laboratories and helps to ensure accurate data generation, controlled test methods and procedures, and properly trained personnel. ISO 17025 covers every aspect of laboratory management, including sample preparation, analytical testing proficiency, report generation and record keeping. The accreditation, awarded by DAP GmbH (Deutsches Akkreditierungssystem Prüfwesen) offers a strong proof of IntegraGen’s high-quality testing services.

Dr Mous added “IntegraGen is proud to be one of the few private laboratories in Germany to obtain this globally-recognized accreditation, which further highlights our commitment to provide customers with the highest quality genetic testing services. Our ISO 17025 accreditation has placed us amongst an elite group of international laboratories offering genetic testing under ISO standard and will certainly increase our standing on an international level, where accreditation will soon become a pre-requisite”.


About IntegraGen
IntegraGen SA uses its unique genomic analysis expertise to identify genes associated with complex diseases and to develop diagnostic and predictive genetic tests. The Company applies its innovative gene mapping technology, GenomeHIP® (Genome Hybrid Identity Profiling), to rapidly discover genetic loci that are implicated in complex, multi-factorial diseases. GenomeHIP® is a major advance that overcomes the limitations of existing marker based familial linkage study methods.

IntegraGen is applying its discoveries to develop a series of innovative IntegraTests™ and is poised to become a leader in the rapidly growing field of predictive medicine. The Company will be a fully integrated provider of genetic tests that can be used to predict, prevent, di


Publisher Contact Information:

IntegraGen SA
+33 (0)1 60 91 09 00
jan.mous@integragen.com

Company profile of IntegraGen SA
Past press releases of IntegraGen SA.

Data


27,746
Tech investments
From our Online Data Service
17,891
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 21€50.0MKnowledge management
Dec 20€16.0MSemiconductors
Dec 17€18.0MOther Computers & Electronics
Dec 17€5.2MBiotechnology
Dec 17€17.0MBusiness applications
Dec 15€17.0ME-Commerce
Dec 4€3.3MNanotechnology

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Sep 30
TetaVi
tetavi raises $6 million to help more companies bring 3d holograms ...

May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Mar 31
CompPair
the fit allocates chf 100'000 to comppair technologies

Jan 29
Yumpingo
yumpingo raises $10m to transform guest experiences in restaurants





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.